Clinical Trial Update: Neovascularization Induced by Mechanical Barrier disrUption and Systemic Erythropoietin in Patients With Cerebral Perfusion Deficits [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating neovascularization induced by mechanical barrier disruption and systemic erythropoietin in patients with cerebral perfusion…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Erythropoietin (erythropoietin)

Snippet

Sponsor: Ajou University School of Medicine | Conditions: Angiogenesis, Ischemic Stroke | Phase 2 | Status: COMPLETED